Human EPO Base Kit

Click image to enlarge

The Human EPO Base Kit provides basic components for the detection of both natural and recombinant human erythropoietin (EPO). Base kits generally include only MSD plates coated with the capture antibody, SULFO-TAG labeled antibody, and MSD proprietary read buffer. (See product insert for a list of kit components.) Base kits are most commonly used for high-throughput screening and assay development.

Specifications
Documentation
References

Application(s)		Hypoxia , Cardiovascular
Analyte(s)		EPO
Species		Human
Instrument(s)		SECTOR Imager 2400 , SECTOR Imager 6000 , MESO QuickPlex SQ 120 , MESO QuickPlex SQ 120MM , MESO SECTOR S 600 , MESO SECTOR S 600MM
Plate Type		96-well
LLOD (Sensitivity)		1 mIU/mL
Dynamic Range		1-10000 mIU/mL
Sample Type		Serum, Plasma
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		2-8 °C

Contact Information

Customer Service/Orders
1-240-314-2795

5:00 a.m. to 8:00 p.m.
US Eastern Time

Email

Scientific/Technical Support
1-240-314-2798

5:30 a.m. to 5:30 p.m.
US Eastern Time

Email

Instrument Support
1-301-947-2057

8:30 a.m. - 5:30 p.m.
US Eastern Time

Email

Company Headquarters
1-240-314-2600
1601 Research Blvd.
Rockville, Maryland 20850-3173
USA

Product Inserts		Human EPO TC
Datasheets		DS Human EPO TC
SDS		Read Buffer T (4x), Read Buffer S (4x) and Read Buffer S (1x)

Title	Journal	Year
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Sun CC, Vaja V, Chen S, Theurl I, Stepanek A, Brown DE, Cappellini MD, Weiss G, Hong CC, Lin HY, Babitt JL.	Nephrol Dial Transplant	2013
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea Doufas AG, Tian L, Padrez KA, Suwanprathes P, Cardell JA, Maecker HT, Panousis P.	PLoS One	2013
Controlled regulation of erythropoietin by primary cultured renal cells for renal failure induced anemia. Gyabaah K, Aboushwareb T, Guimaraes Souza N, Yamaleyeva L, Varner A, Wang HJ, Atala A, Yoo JJ.	J Urol.	2012
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor. Barrett, T.D., Palomino, H.L., Brondstetter, T.I., Kanelakis, K.C., Wu, X., Haug, P.V., Yan, W., Young, A., Hua, H., Hart, J.C., Tran, D.T., Venkatesan, H., Rosen, M.D., Peltier, H.M., Sepassi, K., Rizzolio, M.C., Bembenek, S.D., Mirzadegan, T., Rabinowitz, M.H., Shankley, N.P.	Mol Pharmacol.	2011

Please Sign In

User name

Password

Human EPO Base Kit

Top Products

Contact Information

Products

Services

Orders & Support

Key Topics